Qube Research & Technologies (QRT)
DVAX

Qube Research & Technologies (QRT)’s Dynavax Technologies DVAX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-604,667
Closed -$9.3M – 3651
2025
Q4 		$9.3M Sell
604,667
-149,374
-20% -$1.65M 0.01% 1389
2025
Q3 		$7.49M Buy
754,041
+467,369
+163% +$4.86M 0.01% 1490
2025
Q2 		$2.84M Buy
+286,672
New +$3.02M ﹤0.01% 2025
2024
Q2 		– Sell
-183,785
Closed -$2.28M – 4012
2024
Q1 		$2.28M Buy
183,785
+33,918
+23% +$442K ﹤0.01% 1675
2023
Q4 		$2.1M Buy
+149,867
New +$2.08M ﹤0.01% 1503
2023
Q2 		– Sell
-76,618
Closed -$752K – 2533
2023
Q1 		$752K Sell
76,618
-158,995
-67% -$1.7M ﹤0.01% 1407
2022
Q4 		$2.51M Buy
+235,613
New +$2.74M 0.01% 872
2022
Q2 		– Sell
-27,462
Closed -$298K – 2637
2022
Q1 		$298K Buy
+27,462
New +$334K ﹤0.01% 1788
2020
Q4 		– Sell
-112,859
Closed -$488K – 1893
2020
Q3 		$488K Buy
+112,859
New +$805K 0.01% 1045

Other funds holding DVAX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Qube Research & Technologies (QRT)'s DVAX Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 604,667 shares — an estimated $9.3M sold.

Qube Research & Technologies (QRT) first reported a position in DVAX in Q3 2020 and held it in 9 quarters. The position peaked at $9.3M in Q4 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 604,667 Dynavax Technologies shares in Q1 2026, an estimated $9.3M.
  • Qube Research & Technologies (QRT) first reported a position in Dynavax Technologies in Q3 2020 and held it in 9 quarters.
  • Qube Research & Technologies (QRT)'s Dynavax Technologies position peaked at $9.3M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.